Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00290459 · ClinicalTrials.gov registry record
Prognostic Markers of Gynecologic Cancers
A clinical trial, sponsored by University of Louisville.
- Completed
- Registry status
- 1,321
- Enrollment target
NCT00290459: Completed study, sponsored by University of Louisville.
NCT00290459 is a clinical trial that has completed, run by University of Louisville. The registered enrollment target is 1,321 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00290459 has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- 1,321 participants
- Enrollment target
Study Summary
This proposal seeks to retain "discard" pieces of human gynecologic tissues and "discard" ascites fluid collected during normal surgical procedures, along with corresponding blood samples and urine, for research involving prognostic markers of disease/cancer. The specific aims of the proposal include: 1. To collect "discard" pieces of benign, pre-malignant and malignant gynecologic tissues, "discard" ascites fluid and, when possible, corresponding blood and urine specimens from patients undergoing: 1. hysterectomy 2. excisions of cervical dysplasia and/or venereal warts, and 3. therapeutic excisional surgeries to remove gynecologic disease/cancer (uterine, ovarian and lower female genital tract). 4. paracentesis for the symptomatic relief of ascites fluid accumulation (distention). 2. To collect pre-operative blood and urine from patients along with pre- operative blood work drawn for clinical evaluation. 3. De-identify the patients from their donated tissue, blood and urine specimens by assigning a laboratory identification number. 4. Rapidly process and store the collected specimens to preserve biological integrity. (RNA, DNA and proteins) 5. Collect and record the patient's demographic and medical information into a research database under the assigned lab number only. 6. Assess the specimens for prognostic markers of gynecologic disease/cancer by molecular techniques such as DNA arrays,immunohistochemistry and ELISA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,321 participants |
| Start Date | 2003-12 |
| Est. Completion | 2021-03-26 |
What the finished NCT00290459 record still lists
NCT00290459 is an observational study that tracks outcomes without assigning an intervention. Its 1,321 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00290459 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00290459 about?
NCT00290459 is a clinical study titled "Prognostic Markers of Gynecologic Cancers". This proposal seeks to retain "discard" pieces of human gynecologic tissues and "discard" ascites fluid collected during normal surgical procedures, along with corresponding blood samples and urine, for research involving prognostic markers of disease/cancer. The specific aims of the proposal includ...
What is the current status of trial NCT00290459?
This trial is currently completed. The enrollment target is 1,321 participants. The study started on 2003-12. Estimated completion is 2021-03-26.
Who is sponsoring clinical trial NCT00290459?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06557005 · 1,320 participants · NA
Facilitated Transitions From Postpartum to Primary Care Coordination for People With Chronic Conditions
- NCT07213908 · 1,320 participants · NA
Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth
- NCT07144800 · 1,319 participants · NA
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
- NCT05097287 · 1,324 participants · Phase 4
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia